Umre M A, Choudhary S K, Chander H, Venugopal P, Kumar A S
Department of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, New Delhi.
Indian Heart J. 1998 May-Jun;50(3):318-20.
From March 1994 to March 1997, 36 patients with aortic valve endocarditis were managed surgically. Of these, 30 patients had native valve endocarditis and six had prosthetic valve endocarditis. In patients with native valve endocarditis, surgical procedures included aortic valve repair (n=6), homograft aortic valve replacement (n=9), Ross procedure (n=5) and prosthetic aortic valve replacement (n=10). There were three early and two late deaths in this group. In patients with prosthetic valve endocarditis, aortic valve replacement with a homograft was performed in all. Active infection and prosthetic valve endocarditis were the most important predictors of early mortality. The availability of a homograft valve provides an alternative to prosthetic valve replacement in patients with aortic valve endocarditis.
1994年3月至1997年3月,36例主动脉瓣心内膜炎患者接受了手术治疗。其中,30例为自体瓣膜心内膜炎,6例为人工瓣膜心内膜炎。自体瓣膜心内膜炎患者的手术方式包括主动脉瓣修复(n = 6)、同种异体主动脉瓣置换(n = 9)、罗斯手术(n = 5)和人工主动脉瓣置换(n = 10)。该组有3例早期死亡和2例晚期死亡。人工瓣膜心内膜炎患者均进行了同种异体主动脉瓣置换。活动性感染和人工瓣膜心内膜炎是早期死亡率的最重要预测因素。同种异体瓣膜的可用性为主动脉瓣心内膜炎患者提供了人工瓣膜置换的替代方案。